Moreover, MM patients with high TCF3 expression have significantly shorter survival times than patients with lower levels of TCF3 (GSE39754; P = 0.002, MMRF CoMMpass; P < 0.001) (Supplementary Fig. S7C and D). This evidence concerns the gene TCF3 and Miyoshi myopathy.